Global Medicines Limited, a under cirp public limited company, was established on 02 March 1994 in Uttarsanda, Gujarat, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24230GJ1994PLC021466. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹9.10 M.
It upholds a compliant status. Its leadership includes Girishbhai Jashbhai Patel (Director), Mayurkumar Vishnubhai Patel (Additional Director), Alpeshbhai Girishbhai Patel (Director). Past directors included Sarojben Ashwinkumar Patel, Mukesh Vaswani, Girishbhai Jashbhai Patel. It holds ₹5.23 Cr open charges and no settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at N.H. No-8, Nr. Sadanshah Pir Gutal Road, Ta. Nadiad, Uttarsanda, Gujarat, 387370.
U24230GJ1994PLC021466
021466
02 March 1994
₹2.00 Cr
₹9.10 M
Roc Ahmedabad
Unlisted
Under Cirp
Explore comprehensive insights into Global Medicines Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girishbhai Jashbhai Patel | Director | 17 Jan 2011 | Current |
| Mayurkumar Vishnubhai Patel | Additional Director | 30 Sep 2024 | Current |
| Alpeshbhai Girishbhai Patel | Director | 17 Jan 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Jan 2011 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
| Pramod Abcsdd | Director | 01 Dec 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
| Pramod Abcsdd | Director | 25 Jan 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Global Medicines Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.26% decrease. The company also saw a substantial improvement in profitability, with a 56.5% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Global Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹52,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2012 | Oriental Bank Of Commerce | ₹2.15 Cr | Open |
| 10 May 2012 | Oriental Bank Of Commerce | ₹9.30 M | Open |
| 10 May 2012 | Oriental Bank Of Commerce | ₹2.15 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Global Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Global Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Medicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Global Medicines Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was documented.
The activity Global Medicines Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
The activity Mayurkumar Vishnubhai Patel was appointed as a Additional Director was appointed as a Additional Director on 30 Sep 2024 & has been associated with this company since 1 year 3 months . was completed.
The activity A charge with Oriental Bank Of Commerce of Rs. 2.15 Cr registered on 08 Jun 2012 with Charge ID 10360633 was modified on 14 Sep 2015. was completed.
A charge with Oriental Bank Of Commerce of Rs. 2.15 Cr registered on 10 May 2012 with Charge ID 10362621 was modified on 14 Sep 2015. was recorded as a recent event.
A charge with Oriental Bank Of Commerce amounted to Rs. 2.15 Cr with Charge ID 10360633 was registered on 08 Jun 2012. was recorded as a recent event.
The CIN of Global Medicines Limited is U24230GJ1994PLC021466.
Global Medicines Limited is headquartered at N.H. No-8, Nr. Sadanshah Pir Gutal Road, Ta. Nadiad, Uttarsanda, Gujarat, 387370.
Global Medicines Limited was incorporated on 02 March 1994.
The current directors of Global Medicines Limited are
The primary industry of Global Medicines Limited is Manufacturing.
Global Medicines Limited is unlisted.
The authorized capital of Global Medicines Limited is ₹2.00 Cr, and the paid-up capital is ₹9.10 M.
The compliance status of Global Medicines Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX